Ignite Creation Date:
2024-05-05 @ 5:20 PM
Last Modification Date:
2024-10-26 @ 9:30 AM
Study NCT ID:
NCT00437216
Status:
COMPLETED
Last Update Posted:
2022-07-29
First Post:
2007-02-16
Brief Title:
Efficacy Tolerance and Satisfaction With CLOBEX Spray When Used as Monotherapy or Add-on Therapy in Plaque Psoriasis
Sponsor:
Galderma RD
Organization:
Galderma RD
Organization Data
Organization:
Galderma RD
Class:
INDUSTRY
Study ID:
US10029
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Galderma RD
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
Ronald W Gottschalk MD Medical Director
Old Organization:
Galderma Laboratories LP